BR0304575A - Compostos [3,4-a:3,4-c]carbazol, processo para sua preparação e composições farmacêuticas contendo os mesmos - Google Patents
Compostos [3,4-a:3,4-c]carbazol, processo para sua preparação e composições farmacêuticas contendo os mesmosInfo
- Publication number
- BR0304575A BR0304575A BR0304575-7A BR0304575A BR0304575A BR 0304575 A BR0304575 A BR 0304575A BR 0304575 A BR0304575 A BR 0304575A BR 0304575 A BR0304575 A BR 0304575A
- Authority
- BR
- Brazil
- Prior art keywords
- group
- preparation
- pharmaceutical compositions
- compositions containing
- description
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 125000000609 carbazolyl group Chemical class C1(=CC=CC=2C3=CC=CC=C3NC12)* 0.000 title 1
- UJOBWOGCFQCDNV-UHFFFAOYSA-N 9H-carbazole Chemical compound C1=CC=C2C3=CC=CC=C3NC2=C1 UJOBWOGCFQCDNV-UHFFFAOYSA-N 0.000 abstract 2
- 125000004432 carbon atom Chemical group C* 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 2
- 125000004430 oxygen atom Chemical group O* 0.000 abstract 2
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 125000004414 alkyl thio group Chemical group 0.000 abstract 1
- 229910052799 carbon Inorganic materials 0.000 abstract 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 125000004356 hydroxy functional group Chemical group O* 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 125000004076 pyridyl group Chemical group 0.000 abstract 1
- PXQLVRUNWNTZOS-UHFFFAOYSA-N sulfanyl Chemical class [SH] PXQLVRUNWNTZOS-UHFFFAOYSA-N 0.000 abstract 1
- 125000002813 thiocarbonyl group Chemical group *C(*)=S 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
- C07D487/14—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
- C07D491/14—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/23—Heterocyclic radicals containing two or more heterocyclic rings condensed among themselves or condensed with a common carbocyclic ring system, not provided for in groups C07H19/14 - C07H19/22
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Child & Adolescent Psychology (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Indole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Saccharide Compounds (AREA)
Abstract
"COMPOSTOS [3,4-a:3,4-c]CARBAZOL, PROCESSO PARA SUA PREPARAçãO E COMPOSIçõES FARMACêUTICAS CONTENDO OS MESMOS". Compostos de Fórmula(I) onde: W~ 1~ representa, juntamente com os átomos de carbono aos quais está ligado, um grupo fenila ou um grupo piridila, Z representa um grupo de fórmula U-V conforme indicado na descrição, Q~ 1~ representa um átomo de oxigênio ou um grupo NR~ 2~ conforme indicado na descrição, Q~ 2~ representa um átomo de oxigênio ou um grupo NR<39>~ 2~ conforme indicado na descrição, X~ 1~, X~ 2~, X<39>~ 1~ e X<39>~ 2~ representam, cada qual, um átomo de hidrogênio ou um grupo hidróxi, alcóxi, mercapto ou alquiltio, y~ 1~, Y~ 2~, Y<39>~ 1~, e Y<39>~ 2~ representam, cada qual, um átomo de hidrogênio, ou X~ 1~ e Y~ 1~, X~ 2~ e Y~ 2~, X<39>~ 1~, e Y<39>~ 1~, e X<39>~ 2~ e Y<39>~ 2~ com o átomo de carbono que os porta, formam juntos, um grupo carbonila ou tiocarbonila, R~ 1~ é como já indicado na descrição. Medicamentos.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0212847A FR2845996A1 (fr) | 2002-10-16 | 2002-10-16 | Nouveaux derives de[3,4-a:3,4-c]carbazole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR0304575A true BR0304575A (pt) | 2004-07-20 |
Family
ID=29725330
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR0304575-7A BR0304575A (pt) | 2002-10-16 | 2003-10-15 | Compostos [3,4-a:3,4-c]carbazol, processo para sua preparação e composições farmacêuticas contendo os mesmos |
Country Status (25)
| Country | Link |
|---|---|
| US (1) | US7151108B2 (pt) |
| EP (1) | EP1411057B1 (pt) |
| JP (1) | JP2004277404A (pt) |
| KR (1) | KR100502250B1 (pt) |
| CN (1) | CN1241925C (pt) |
| AR (1) | AR041618A1 (pt) |
| AT (1) | ATE294181T1 (pt) |
| AU (1) | AU2003254746A1 (pt) |
| BR (1) | BR0304575A (pt) |
| CA (1) | CA2443585A1 (pt) |
| DE (1) | DE60300571T2 (pt) |
| DK (1) | DK1411057T3 (pt) |
| EA (1) | EA007250B1 (pt) |
| ES (1) | ES2240927T3 (pt) |
| FR (1) | FR2845996A1 (pt) |
| MA (1) | MA27007A1 (pt) |
| MX (1) | MXPA03009362A (pt) |
| MY (1) | MY134620A (pt) |
| NO (1) | NO20034614L (pt) |
| NZ (1) | NZ528902A (pt) |
| PL (1) | PL362885A1 (pt) |
| PT (1) | PT1411057E (pt) |
| SG (1) | SG131765A1 (pt) |
| SI (1) | SI1411057T1 (pt) |
| ZA (1) | ZA200308053B (pt) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI499414B (zh) | 2006-09-29 | 2015-09-11 | Lexicon Pharmaceuticals Inc | 鈉與葡萄糖第２型共同運輸體（ｃｏ-ｔｒａｎｓｐｏｒｔｅｒ ２）的抑制物與其應用方法 |
| WO2008109591A1 (en) | 2007-03-08 | 2008-09-12 | Lexicon Pharmaceuticals, Inc. | Phlorizin analogs as inhibitors of sodium glucose co-transporter 2 |
| CA2939164A1 (en) | 2014-02-12 | 2015-08-20 | Iteos Therapeutics | Novel 3-(indol-3-yl)-pyridine derivatives, pharmaceutical compositions and methods for use |
| CN103804278B (zh) * | 2014-02-19 | 2016-04-13 | 西北大学 | 一种天然产物2-甲基-3-甲氧基-咔唑-1,4-苯醌的制备方法 |
| PE20170247A1 (es) | 2014-05-15 | 2017-03-29 | Iteos Therapeutics | Derivados de pirrolidina-2,5-diona, composiciones farmaceuticas y metodos para usar como inhibidores ido1 |
| WO2016147144A1 (en) | 2015-03-17 | 2016-09-22 | Pfizer Inc. | Novel 3-indol substituted derivatives, pharmaceutical compositions and methods for use |
| JP2016216446A (ja) * | 2015-05-14 | 2016-12-22 | ファイザー・インク | ピロリジン−２，５−ジオン誘導体の多形形態、医薬組成物、およびｉｄｏ１阻害薬としての使用方法 |
| EP3334733A1 (en) | 2015-08-10 | 2018-06-20 | Pfizer Inc | 3-indol substituted derivatives, pharmaceutical compositions and methods for use |
| CN106832175B (zh) * | 2017-02-17 | 2019-10-18 | 华南理工大学 | 一种基于咔唑衍生物的双羟基荧光扩链剂及其制备与应用 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3010675B2 (ja) * | 1989-03-23 | 2000-02-21 | 萬有製薬株式会社 | 抗腫瘍性物質ｂｅ―１３７９３ｃ |
-
2002
- 2002-10-16 FR FR0212847A patent/FR2845996A1/fr not_active Withdrawn
-
2003
- 2003-09-19 MY MYPI20033597A patent/MY134620A/en unknown
- 2003-09-26 US US10/672,418 patent/US7151108B2/en not_active Expired - Fee Related
- 2003-09-26 MA MA27327A patent/MA27007A1/fr unknown
- 2003-10-13 MX MXPA03009362A patent/MXPA03009362A/es active IP Right Grant
- 2003-10-14 ES ES03292545T patent/ES2240927T3/es not_active Expired - Lifetime
- 2003-10-14 DK DK03292545T patent/DK1411057T3/da active
- 2003-10-14 SI SI200330032T patent/SI1411057T1/xx unknown
- 2003-10-14 DE DE60300571T patent/DE60300571T2/de not_active Expired - Fee Related
- 2003-10-14 PT PT03292545T patent/PT1411057E/pt unknown
- 2003-10-14 AT AT03292545T patent/ATE294181T1/de not_active IP Right Cessation
- 2003-10-14 EP EP03292545A patent/EP1411057B1/fr not_active Expired - Lifetime
- 2003-10-15 PL PL03362885A patent/PL362885A1/xx not_active Application Discontinuation
- 2003-10-15 KR KR10-2003-0071768A patent/KR100502250B1/ko not_active Expired - Fee Related
- 2003-10-15 NO NO20034614A patent/NO20034614L/no not_active Application Discontinuation
- 2003-10-15 NZ NZ528902A patent/NZ528902A/en unknown
- 2003-10-15 CA CA002443585A patent/CA2443585A1/fr not_active Abandoned
- 2003-10-15 AR ARP030103744A patent/AR041618A1/es unknown
- 2003-10-15 BR BR0304575-7A patent/BR0304575A/pt not_active IP Right Cessation
- 2003-10-15 EA EA200301020A patent/EA007250B1/ru unknown
- 2003-10-16 CN CNB200310100563XA patent/CN1241925C/zh not_active Expired - Fee Related
- 2003-10-16 JP JP2003355815A patent/JP2004277404A/ja active Pending
- 2003-10-16 SG SG200306491-2A patent/SG131765A1/en unknown
- 2003-10-16 ZA ZA200308053A patent/ZA200308053B/xx unknown
- 2003-10-16 AU AU2003254746A patent/AU2003254746A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EP1411057A1 (fr) | 2004-04-21 |
| PT1411057E (pt) | 2005-08-31 |
| MY134620A (en) | 2007-12-31 |
| SG131765A1 (en) | 2007-05-28 |
| EA200301020A1 (ru) | 2004-04-29 |
| US7151108B2 (en) | 2006-12-19 |
| ATE294181T1 (de) | 2005-05-15 |
| US20040077672A1 (en) | 2004-04-22 |
| JP2004277404A (ja) | 2004-10-07 |
| DK1411057T3 (da) | 2005-08-29 |
| AU2003254746A1 (en) | 2004-05-06 |
| NZ528902A (en) | 2004-09-24 |
| NO20034614D0 (no) | 2003-10-15 |
| MA27007A1 (fr) | 2004-12-20 |
| EP1411057B1 (fr) | 2005-04-27 |
| DE60300571D1 (de) | 2005-06-02 |
| KR20040034472A (ko) | 2004-04-28 |
| ES2240927T3 (es) | 2005-10-16 |
| NO20034614L (no) | 2004-04-19 |
| ZA200308053B (en) | 2004-07-08 |
| CA2443585A1 (fr) | 2004-04-16 |
| HK1063321A1 (en) | 2004-12-24 |
| MXPA03009362A (es) | 2004-04-28 |
| SI1411057T1 (pt) | 2005-08-31 |
| DE60300571T2 (de) | 2006-02-23 |
| PL362885A1 (en) | 2004-04-19 |
| KR100502250B1 (ko) | 2005-07-20 |
| CN1241925C (zh) | 2006-02-15 |
| CN1496989A (zh) | 2004-05-19 |
| AR041618A1 (es) | 2005-05-26 |
| FR2845996A1 (fr) | 2004-04-23 |
| EA007250B1 (ru) | 2006-08-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0418031A (pt) | inibidores de quinase fosfonato-substituìdos | |
| ECSP045229A (es) | Piridinonas sustituidas como moduladores de la p38 map quinasa | |
| MY140693A (en) | [1,8]naphthyridin-2-ones and related compounds for the treatment of schizophrenia | |
| BRPI0517423A (pt) | composto, composição farmacêutica, método para o tratamento ou prevenção de distúrbios neurológicos e psiquiátricos associados com disfunção do glutamato em um animal, e, uso em um composto | |
| SV1999000048A (es) | Uso de dihidropiriminas como medicamento y nuevas sustancias ref. lea 32 791-sv | |
| BRPI0415683A (pt) | inibidores da reabsorção de norepinefrina para o tratamento de distúrbios do sistema nervoso central | |
| BRPI0412347A (pt) | 2-aminofenil-4-fenilpiridinas como inibidores de quinase | |
| BR0312695A (pt) | Derivados de 1h-pirrolidina-2,4-diona espirocìclicos substituìdos por cis-alcóxi | |
| BRPI0413934A (pt) | compostos orgánicos | |
| ECSP034831A (es) | Derivados sustituidos de la 2-piridina ciclohexano-1,4-diamina | |
| BRPI0409680A (pt) | análogos de fosfonato anti-cáncer | |
| GEP20125643B (en) | Aurora kinase modulators and method of using same | |
| BR0208887A (pt) | Derivados de dihidro-benzo[b][1,4]diazepin-2-ona como antagonistas i de mglur2 | |
| BRPI0410238A (pt) | compostos orgánicos | |
| BR0314379A (pt) | Quinazolinonas espirocondensadas e a sua utilização como inibidores de fosfodiesterase | |
| BRPI0414948A (pt) | derivados de pirazolo-e-imidazo pirimidina | |
| BR9909739A (pt) | Benzotiadiazóis e derivados | |
| BRPI0507054A (pt) | bloqueadores do canal de cálcio tipo n | |
| BR0304575A (pt) | Compostos [3,4-a:3,4-c]carbazol, processo para sua preparação e composições farmacêuticas contendo os mesmos | |
| PT1259498E (pt) | Derivados do 8,8a-di-hidroindeno[1,2-d]tiazole substituidos na posicao 8a, processo para a sua preparacao e sua utilizacao como medicamentos, p. ex. como anorecticos | |
| CY1109569T1 (el) | Υποκατεστημενα παραγωγα κυκλοεξανο-1,4-διαμινης | |
| BR0210698A (pt) | Compostos de pirido-pirido-pirrolo[3,2-g]pirrolo[3,4-e]indol e pirido-pirrolo[2,3-a]pirrolo[3,4-c]carbazol, um processo para a sua preparação e composições farmacêuticas contendo-os | |
| BRPI0512986A (pt) | novos derivados de hidantoìna | |
| TW200714598A (en) | Urea derivatives, methods for their manufacture, and uses therefor | |
| BRPI0403028A (pt) | Compostos heterocìclicos de oxima, processo para sua preparação e composições farmacêuticas contendo os mesmos |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B03H | Publication of an application: rectification [chapter 3.8 patent gazette] | ||
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 5A E 6A ANUIDADES |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2042 DE 23/02/2010. |